Rob Commons

Infectious Diseases Physician | PhD Student @MenziesResearch | Global Health | Malaria

[Kamala Thriemer @KThriemer]

Great to see results from the #INSPECTOR study out in @TheLancetInfDis https://t.co/OfqYHoroZL. Tafenoquine (TQ) with ACTs showed low efficacy in Papua, Indonesia and results already led to a label change. Was this too premature? A thread (1/4)

[Rob Commons @RobCommons]

Important @TheLancetInfDis study by Sutanto et al https://t.co/2C0xPODIjr that led to label change for tafenoquine to not be administered with ACTs #vivax #malaria. Commentary by @KThriemer & I highlights need for further studies in different populations https://t.co/ESO76GJitw

[Am J Trop Med Hyg @AJTMH]

Estimating the Proportion of #Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis https://t.co/HrSLGQysz0 @ricprice99 @MenziesResearch @CDUni @BallaratHealth @unimelb @SciMelb @MORUBKK @jwato_watson @TropMedOxford @ASTMH

[WWARN @wwarnnews.bsky.social @WWARN]

New research from @RobCommons @ricprice99 in @PLOSMedicine supports co-administration of primaquine with artemisinin-based combination therapies for P. vivax #malaria https://t.co/wsHCpbKctH Photo: UNICEF, Iman Morooka

[Ric Price @ricprice99]

The IMPROV trial out today in @TheLancet. 7d vs 14d high dose Primaquine for #vivax malaria - 7d as effective as 14d with acceptable tolerance. The shorter course regimen offers hope of a more practical regimen for the radical cure of #malaria
https://t.co/NXuy1jlpj5

[Ric Price @ricprice99]

Second indication for tafenoquine also approved by the FDA. This time for prevention #malaria
https://t.co/097XoHXFZ7

[Rob Commons @RobCommons]

“Malaria is very clever — it hides out where you don’t know and comes back when you aren’t ready" - candid story on the risk of drug resistant malaria in the Mekong region. @MORU @amymaxmen #malaria #malariaelimination https://t.co/sXVbIfmgQo

[Rob Commons @RobCommons]

Major breakthrough for vivax malaria. First new drug to treat dormant liver stage and prevent relapse in 60 years. #malaria #malariaelimination

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

First ever FDA-approved #singledose medicine to prevent relapse of P. vivax malaria developed by MMV and @GSK, marking breakthrough in drive towards malaria eradication. https://t.co/5RasZizk0E

[Ric Price @ricprice99]

Plus for the last 60 years, we have probably been under-dosing chloroquine for #vivax malaria !

[Rob Commons @RobCommons]

A demonstration of how collaboration can assist in improving the tools we have to control malaria. #malaria #malariaelimination @WWARN @ricprice99 @MenziesResearch

[WWARN @wwarnnews.bsky.social @WWARN]

A @WWARN @MenziesResearch IPD analysis of 5000 patients with p.vivax from 37 studies in 17 countries shows revised primaquine + chloroquine dose can lead to better result in #malaria patients https://t.co/PPH839skHr @TheLancet @ricprice99 @MORUBKK @TropMedOxford #Malariamustdie

[Dr Julia Cutts @julia_cutts]

Great to see the malaria elimination message on a Melbourne billboard!The chilly weather may mislead, but ending malaria is relevant to Aussies. @MalariaCongress @acreme2030 @APLMA_Malaria https://t.co/Vhr2C1qrGk